Morgan Stanley Downgrades Merck (MRK) to Underweight
Tweet Send to a FriendGet Alerts MRK Hot Sheet
Price: $45.99 -0.82%
Rating Summary:
8 Buy, 5 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Rating Summary:
8 Buy, 5 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Trade MRK Now!
Morgan Stanley downgraded Merck (NYSE: MRK) from Equalweight to Underweight.
NOTE: Second downgrade today.
For an analyst ratings summary and ratings history on Merck click here. For more ratings news on Merck click here.
Shares of Merck closed at $41.83 yesterday, with a 52 week range of $36.91-$48.00.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
NOTE: Second downgrade today.
For an analyst ratings summary and ratings history on Merck click here. For more ratings news on Merck click here.
Shares of Merck closed at $41.83 yesterday, with a 52 week range of $36.91-$48.00.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Macquarie Downgrades Barrick Gold (ABX) to Underperform
- Baird Downgrades Brocade (BRCD) to Neutral
- Merck to Present at the UBS Global Healthcare Conference
Create E-mail Alert Related Categories
DowngradesRelated Entities
Morgan Stanley
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
